42 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Orbsat Corp. OSAT shares jumped 74% to $9.47.
• BSQUARE Corporation BSQR shares jumped 48.2% to $5.90 after dropping around 10% on Friday.
• Bridgeline Digital, Inc. BLIN shares jumped 41.3% to $12.67 after jumping 56% on Friday. Bridgeline Digital, last week, announced its partner network won more than 20 site search licenses this quarter for Celebros and HawkSearch, its most recent acquisition.
• PFSweb, Inc. PFSW gained 39.8% to $10.59 after the company agreed to sell LiveArea business to Merkle for $250 million.
• Sequential Brands Group, Inc. SQBG shares climbed 37% to $21.50 after jumping 89% on Friday.
• Advaxis, Inc. ADXS shares climbed 27.4% to $0.6011 after the company announced it entered into a definitive merger agreement with Biosight and Biosight shareholders will become majority shareholders in the combined company.
• Marin Software Incorporated MRIN climbed 25% to $25.34 after climbing around 35% on Friday amid continued extreme volatility and volume in the stock from investors following the company's Instacart Ads integration announcement.
• Clearside Biomedical, Inc. CLSD gained 25% to $6.72.
• Larimar Therapeutics, Inc. LRMR surged 20.5% to $11.92.
• Atossa Therapeutics, Inc. ATOS gained 15.3% to $6.19 after dropping 16% on Friday.
• Taiwan Liposome Company, Ltd. TLC jumped 15.2% to $6.60. TLC recently announced details of stock swap transactions.
• Axcella Health Inc. AXLA surged 14.6% to $4.55 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $14 price target.
• Bon Natural Life Limited BON climbed 14.4% to $9.21 after the company received the certificate of a land use right for the future site of its third production facility in the city of Yumen.
• Cleveland BioLabs, Inc. CBLI jumped 13.7% to $6.61. The company today conducted a merger vote.
• Tempest Therapeutics Inc. TPST gained 13% to $12.68. Piper Sandler initiated coverage on Tempest Therapeutics with an Overweight rating and announced a price target of $23.
• Xcel Brands, Inc. XELB gained 13% to $3.0853.
• Alector, Inc. ALEC gained 11.7% to $39.39. Alector and GlaxoSmithKline recently announced a global collaboration for the development and commercialization of two monoclonal antibodies designed to elevate progranulin (PGRN) levels.
• Data Storage Corporation DTST climbed 10% to $6.49.
• Odonate Therapeutics, Inc. ODT shares gained 8.4% to $3.76 following 13G from Ikarian Capital showing a 5.2% stake in the company.
• Ocugen, Inc. OCGN shares gained 7.4% to $7.84. Armed with new data from its development partner Bharat Biotech, Ocugen plans to press ahead with plans to file for approval of their COVID-19 vaccine, Covaxin, in the U.S. and Canada.
• Cytosorbents Corporation CTSO gained 7.2% to $7.88 after the company received full FDA approval for its U.S. STAR-T trial on ticagrelor removal during cardiothoracic surgery.
• Cano Health, Inc. CANO rose 4% to $12.50 in pre-market trading as the company said it has acquired Doctor's Medical Center for $300 million.

Check out these big penny stock gainers and losers

Losers

• Pop Culture Group Co., Ltd CPOP dipped 33.7% to $35.40 after dropping over 10% on Friday. Pop Culture Group recently priced its IPO at $6 per share.
• Provention Bio, Inc. PRVB shares dipped 29.6% to $5.84. The FDA has issued a Complete Response Letter (CRL) to Provention Bio’s teplizumab marketing application seeking approval for the delay of clinical type 1 diabetes (T1D) in at-risk individuals.
• Ashford Hospitality Trust, Inc. AHT dropped 27.8% to $2.86 after the company announced preliminary Q2 RevPAR results.
• DiDi Global Inc. DIDI shares declined 23.3% to $11.91 after the company announced its app is being removed from Chinese app stores due to personal data collection concerns by the Chinese government.
• Full Truck Alliance Co. Ltd. YMM shares fell 20.1% to $15.19. The company, last month, priced its IPO at $19 per ADS.
• DouYu International Holdings Limited DOYU dropped 14.3% to $5.70. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.
• HUTCHMED (China) Limited HCM dipped 14% to $34.71. HUTCHMED said it initiated Phase I trials of novel ERK inhibitor HMPL 295 in patients with advanced solid tumors in China.
• Zhihu Inc. ZH fell 13.9% to $10.76. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.
• UP Fintech Holding Limited TIGR tumbled 13.1% to $22.23. Shares of Chinese companies traded lower amid regulatory concerns after Chinese regulators suggested Didi delay its US IPO said they will step up regulation on Chinese firms listed offshore.
• Staffing 360 Solutions, Inc. STAF shares fell 13% to $4.34 after jumping around 35% on Friday.
• Limelight Networks, Inc. LLNW dropped 12.5% to $2.71. Goldman Sachs analyst Brett Feldman downgraded the rating on edge cloud services provider Limelight Networks from Neutral to Sell.
• Stride, Inc. LRN shares declined 12.1% to $28.64.
• Alterity Therapeutics Limited ATHE fell 12% to $1.5410. Alterity Therapeutics recently announced it was granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's..
• Tuya Inc. TUYA dipped 11.6% to $22.13.
• Kanzhun Limited BZ fell 11.4% to $32.17.
• Tata Motors Limited TTM shares fell 10.7% to $20.62. Jaguar Land Rover reduced its estimates for deliveries to car dealers.
• Auddia Inc.AUUD shares fell 10.1% to $6.67. Auddia recently announced the release and national launch of its flagship Auddia app ahead of schedule.
• Clover Health Investments, Corp. CLOV dropped 9.9% to $10.55.
• Tencent Music Entertainment Group TME fell 9.8% to $13.63.
• Missfresh Limited MF shares declined 8% to $7.90. The company recently priced its IPO at $13 per share.